Kenneth Marek

Institute for Neurodegenerative Disorders

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.9Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Concordance for Parkinson's disease in twins: A 20‐year update

Annals of Neurology(2019)10.1002/ana.25441

Top 8%

2.8DataRank

Top 8%110 citations

Kenneth Marek, Ruth Ottman, Cheryl Meng, Kathleen Comyns, Piu Chan +6 more

Papers

Driven by 38 papers — median percentile 75. Top paper: “Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression”.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

JAMA(2021)10.1001/jama.2021.10207

N/A

4.5DataRank · unranked

160 citations

Brent Bluett, Daniel M. Togasaki, Dragos Mihaila, Marian L. Evatt, Michael Rezak +95 more

Concordance for Parkinson's disease in twins: A 20‐year update

Annals of Neurology(2019)10.1002/ana.25441

Top 8%

2.8DataRank

Top 8%110 citations

Kenneth Marek, Ruth Ottman, Cheryl Meng, Kathleen Comyns, Piu Chan +6 more

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433

Top 12%

1.7DataRank

Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

Journal of Parkinson s Disease(2021)10.3233/jpd-212714

N/A

1.7DataRank · unranked

61 citations

on behalf of the MOVES-PD Investigators, Hidemoto Saiki, Taku Hatano, Thomas Gasser, Stuart Isaacson +17 more

A proteogenomic view of Parkinson’s disease causality and heterogeneity

npj Parkinson s Disease(2023)10.1038/s41531-023-00461-9

N/A

1.4DataRank · unranked

56 citations

Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge L. Del‐Aguila +24 more

Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00872-x

N/A

1.3DataRank · unranked

93 citations

Megan Mariani, Charles H. Adler, Laura J. Balcer, Charles Bernick, Rhoda Au +41 more

Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial

Nature Medicine(2024)10.1038/s41591-024-03270-6

N/A

0.908DataRank · unranked

51 citations

Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda, Thomas Kustermann +17 more

Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players

European Journal of Nuclear Medicine and Molecular Imaging(2022)10.1007/s00259-022-05963-x

N/A

0.814DataRank · unranked

27 citations

Yi Su, Thor D. Stein, Hillary Protas, Jonathan D. Cherry, Charles H. Adler +80 more

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

npj Parkinson s Disease(2024)10.1038/s41531-024-00789-w

Top 25%

0.813DataRank

Top 25%37 citations

Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub +95 more

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

The Lancet Neurology(2015)10.1016/s1474-4422(15)00178-7

N/A

0.811DataRank · unranked

222 citations

Cory Y. McLean, Jacqueline Rick, Shirley Eberly, Samantha J. Hutten, Katrina Gwinn +40 more

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Movement Disorders(2020)10.1002/mds.28206

N/A

0.798DataRank · unranked

204 citations

Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg +21 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

npj Parkinson s Disease(2022)10.1038/s41531-022-00404-w

Top 26%

0.783DataRank

Top 26%19 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +85 more

Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

Movement Disorders Clinical Practice(2023)10.1002/mdc3.13751

N/A

0.688DataRank · unranked

11 citations

Marina Picillo, Hyunkeun Ryan Cho, Chelsea Caspell‐Garcia, Cornelis Blauwendraat, Ethan Brown +17 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699

N/A

0.654DataRank · unranked

77 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Amyloid PET across the cognitive spectrum in former professional and college American football players: findings from the DIAGNOSE CTE Research Project

Alzheimer s Research & Therapy(2023)10.1186/s13195-023-01315-5

N/A

0.650DataRank · unranked

27 citations

Diana Trujillo‐Rodriguez, Yorghos Tripodis, Surya Pulukuri, Michael L. Alosco, Charles H. Adler +95 more

Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science

Digital Biomarkers(2020)10.1159/000512500

N/A

0.631DataRank · unranked

66 citations

Robert Alexander, Varun Aggarwal, Reham Badawy, Lisa J. Bain, Roopal Bhatnagar +37 more

Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project

Alzheimer s & Dementia(2023)10.1002/alz.13602

Top 34%

0.570DataRank

Top 34%20 citations

Hillary Protas, Ji Luo, Kewei Chen, Michael L. Alosco, Charles H. Adler +25 more

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.04.502846

N/A

0.312DataRank · unranked

7 citations

Vipul Satone, Rachneet Kaur, Sayed Hadi Hashemi, Hampton L. Leonard, Hirotaka Iwaki +14 more

LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates

medRxiv(2024)10.1101/2024.07.22.24310806

N/A

0.241DataRank · unranked

4 citations

David-Erick Lafontant, Seung Ho Choi, Hirotaka Iwaki, Cornelis Blauwendraat, Andrew Singleton +20 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1

N/A

0.104DataRank · unranked

1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts.

Research Square(2022)10.21203/rs.3.rs-1931095/v1

N/A

0.104DataRank · unranked

1 citations

Anant Dadu, Vipul Satone, Rachneet Kaur, Sayed Hashemi, Hampton L. Leonard +14 more

Parkinson’s disease causality and heterogeneity: a proteogenomic view

Research Square(2022)10.21203/rs.3.rs-1787250/v1

N/A

0.104DataRank · unranked

1 citations

Sérgio Kaiser, Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich +24 more

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging

medRxiv(2024)10.1101/2024.10.27.24316215

N/A

0DataRank · unranked

1 citations

Michael Ta, Nicholas J. Tustison, Ali Daneshmand, Kenneth Marek, Andrew Singleton +6 more

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia

medRxiv(2024)10.1101/2024.12.12.24318917

N/A

0DataRank · unranked

0 citations

Anuprita R Nair, Ryan Kurth, Michael C. Brumm, Michele K. York, Roseanne D. Dobkin +20 more

Neuronal alpha-Synuclein Disease stage progression over five years

medRxiv(2024)10.1101/2024.12.17.24319172

Top 100%

0DataRank

Top 100%0 citations

Caroline Gochanour, Anuprita R Nair, Michael C. Brumm, Christopher S. Coffey, Kathleen L. Poston +14 more

Toward a biological definition of neuronal and glial synucleinopathies

Nature Medicine(2025)10.1038/s41591-024-03469-7

N/A

0DataRank · unranked

19 citations

Brit Mollenhauer, Oskar Hansson, Un Jung Kang, Roy N. Alcalay, David G. Standaert +5 more

Reply to: “Refutation of the αSyn ‐ SAA ‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD ‐ ISS] )”

Movement Disorders(2025)10.1002/mds.30272

N/A

0DataRank · unranked

1 citations

Lana M. Chahine, Kathleen L. Poston, Catherine Kopil, Daniel Weintraub, Billy Dunn +2 more

Clinical and imaging characteristics of Parkinson’s disease with negative alpha-synuclein seed amplification assay

medRxiv(2025)10.1101/2025.10.01.25337085

N/A

0DataRank · unranked

1 citations

Jacopo Pasquini, Seung Ho Choi, David-Erick Lafontant, Seyed‐Mohammad Fereshtehnejad, Yashar Zeighami +25 more

Parkinson’s disease causality and heterogeneity: a proteogenomic view

medRxiv(2022)10.1101/2022.03.09.22272131

N/A

0DataRank · unranked

3 citations

Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge L. Del‐Aguila +24 more

The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease

medRxiv(2020)10.1101/2020.07.14.20153023

N/A

0DataRank · unranked

4 citations

Lana M. Chahine, Samuel M. Goldman, Monica Korell, Emerald Mann, Daniel Kinel +4 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers: The PPMI cohort

Research Square(2022)10.21203/rs.3.rs-1719882/v1

N/A

0DataRank · unranked

3 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +11 more

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Annals of Neurology(2020)10.1002/ana.25811

N/A

0DataRank · unranked

111 citations

Janel Fedler, Christopher S. Coffey, Chelsea Caspell‐Garcia, Ju‐Hee Kang, Tanya Simuni +16 more

Planning for Prevention of Parkinson Disease

Neurology(2022)10.1212/wnl.0000000000200789

N/A

0DataRank · unranked

30 citations

Jessi L. Keavney, Roy N. Alcalay, Kenneth Marek, Gad A. Marshall, H. Diana Rosas +2 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2

N/A

0DataRank · unranked

42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more

Neuropsychological test performance of former American football players

Alzheimer s Research & Therapy(2023)10.1186/s13195-022-01147-9

N/A

0DataRank · unranked

38 citations

William Barr, Sarah J. Banks, Jennifer V. Wethe, Justin B. Miller, Surya Pulukuri +95 more

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts

npj Parkinson s Disease(2022)10.1038/s41531-022-00439-z

N/A

0DataRank · unranked

112 citations

Vipul Satone, Rachneet Kaur, Sayed Hadi Hashemi, Hampton L. Leonard, Hirotaka Iwaki +14 more

Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000208033

N/A

0DataRank · unranked

23 citations

David J. Irwin, Thomas F. Tropea, Emma Rhodes, Jeffrey S. Phillips, Alice S. Chen-Plotkin +18 more

Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants

Journal of Parkinson s Disease(2024)10.3233/jpd-240015

N/A

0DataRank · unranked

18 citations

Samuel M. Goldman, Christopher S. Coffey, Andrew Siderowf, Tanya Simuni, Cheryl Meng +6 more

Kenneth Marek

Indexed papers

Top data-sharing exemplar

Papers